Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Synthetic MR AB's EV-to-EBIT or its related term are showing as below:
LTS:0G79'
s EV-to-EBIT Range Over the Past 10 Years
Min: -414.37 Med: 101.07 Max: 2091.25
Current: -0.54
During the past 13 years, the highest EV-to-EBIT of Synthetic MR AB was 2091.25. The lowest was -414.37. And the median was 101.07.
LTS:0G79's EV-to-EBIT is ranked worse than 100% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 15.88
vs LTS:0G79: -0.54
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Synthetic MR AB's Enterprise Value for the quarter that ended in Mar. 2026 was kr1,417.11 Mil.
Synthetic MR AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-45.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthetic MR AB EV-to-EBIT Related Terms
Synthetic MR AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Synthetic MR AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0G79 vs VEEV, BTSG, HQY: EV-to-EBIT Comparison
For the Health Information Services subindustry, Synthetic MR AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthetic MR AB EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Synthetic MR AB's EV-to-EBIT falls into.
Synthetic MR AB's current Enterprise Value is kr24.40 Mil.
Synthetic MR AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-45.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthetic MR AB (LTS:0G79) has a EV-to-EBIT of -0.54 as of Aug. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Synthetic MR AB and its competitors. According to the industry distribution chart, Synthetic MR AB ranks #999999 out of 476 companies in the Healthcare Providers & Services industry.
Is Synthetic MR AB's EV-to-EBIT too high?
Synthetic MR AB's current EV-to-EBIT is -0.54. Based on the distribution chart, Synthetic MR AB ranks #999999 out of 476 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Synthetic MR AB has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #999999 out of 476 companies for EV-to-EBIT. This places Synthetic MR AB in the lower half of its industry. The industry median EV-to-EBIT is 15.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.88, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Synthetic MR AB and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current EV-to-EBIT is -0.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Synthetic MR AB (LTS:0G79) has a current EV-to-EBIT of -0.54. The stock's GF Value™ is kr115.29, compared to a current price of kr16.23 — trading 85.9% below its estimated fair value. The current EV-to-EBIT is -0.54. Synthetic MR AB's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Synthetic MR AB (LTS:0G79), the current EV-to-EBIT is -0.54 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synthetic MR AB (LTS:0G79) Overvalued in 2026?
Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued.
The current stock price of kr16.23 is trading 85.9% below its estimated GF Value™ of kr115.29.
Key valuation signals for LTS:0G79:
EV-to-EBIT: -0.54
GF Value™: kr115.29 vs. price of kr16.23 (85.9% below fair value)
No single metric tells the full story. See the LTS:0G79 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
64GF Score
Get the complete analysis for LTS:0G79
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0G79 has been successfully added to your 
